Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study

BACKGROUND: Epidermal growth factor receptor (EGFR) mutations (EGFRm) represent one of the most common genomic alterations identified among patients with non-small cell lung cancer (NSCLC). Several targeted agents for patients with EGFRm have been proven safe and effective, including the third-gener...

Descripción completa

Detalles Bibliográficos
Autores principales: Chamorro, Diego F., Cardona, Andrés F., Rodríguez, July, Ruiz-Patiño, Alejandro, Arrieta, Oscar, Moreno-Pérez, Darwin A., Rojas, Leonardo, Zatarain-Barrón, Zyanya Lucia, Ardila, Dora V., Viola, Lucia, Recondo, Gonzalo, Blaquier, Juan B., Martín, Claudio, Raez, Luis, Samtani, Suraj, Ordóñez-Reyes, Camila, Garcia-Robledo, Juan Esteban, Corrales, Luis, Sotelo, Carolina, Ricaurte, Luisa, Cuello, Mauricio, Mejía, Sergio, Jaller, Elvira, Vargas, Carlos, Carranza, Hernán, Otero, Jorge, Archila, Pilar, Bermudez, Maritza, Gamez, Tatiana, Russo, Alessandro, Malapelle, Umberto, de Miguel Perez, Diego, de Lima, Vladmir C. Cordeiro, Freitas, Helano, Saldahna, Erick, Rolfo, Christian, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192162/
https://www.ncbi.nlm.nih.gov/pubmed/37017806
http://dx.doi.org/10.1007/s11523-023-00955-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192162/
https://www.ncbi.nlm.nih.gov/pubmed/37017806
http://dx.doi.org/10.1007/s11523-023-00955-9

Ejemplares similares